https://www.thebodypro.com/author/sean-r-hosein
Sean Hosein

Sean R. Hosein

Sean R. Hosein is the science and medical editor of CATIE, a prominent Canadian HIV news and information resource. He has been covering HIV news since 1988. CATIE profiled Hostein in 2014 for its landmark 200th TreatmentUpdate issue.

Latest by Sean R. Hosein

doctor looking at list talking to patient
News Analysis

British Columbia Study Finds That Providing ART and Methadone in the Same Facility Helps Adherence

The scientists noted that daily ingestion of methadone provides an opportunity to supervise the consumption of HIV medications in places where methadone is dispensed.

hepatitis word cloud
News Analysis

Trends in Deaths Among People With Hepatitis C Virus in British Columbia

A new study puts numbers to increasingly divergent trends in liver-related deaths vs. injection-related deaths in recent years, highlighting both the success of modern HCV treatment and the devastating effects of the opioid crisis.

Overdoses and Smoking Are Taking the Lives of People With HIV Who Have Been Cured of Hepatitis C Img
Hepatitis C

Overdoses and Smoking Are Taking the Lives of People With HIV Who Have Been Cured of Hepatitis C

"Providing HCV treatment alone while neglecting to concurrently address the social determinants of health will do little to improve the health outcomes of the majority of individuals with chronic HCV," the study authors wrote.

Large French Study Examines Neuropsychiatric Side Effects With Integrase Inhibitors Img
Neurocognitive

Large French Study Examines Neuropsychiatric Side Effects With Integrase Inhibitors

This will likely become the landmark study about the overall rate of neuropsychiatric side effects with this class of medicines over the next several years.

De-Simplifying Single-Tablet Regimens for HIV Treatment Img

De-Simplifying Single-Tablet Regimens for HIV Treatment

A Canadian study of this cost-saving approach found high acceptance of de-simplification among people already on a single-tablet regimen, and even higher rates among people who were just initiating single-tablet treatment.

Dual Maintenance Therapy With Dolutegravir + Rilpivirine Img
News Analysis

Dual Maintenance Therapy With Dolutegravir + Rilpivirine

In clinical trials called Sword 1 and Sword 2, researchers testing a combination of dolutegravir/rilpivirine (Juluca) found it to be effective and tolerable.

Monkey Study Uncovers the Potential for Vesatolimod and Antibodies in HIV Cure Research Img

Monkey Study Uncovers the Potential for Vesatolimod and Antibodies in HIV Cure Research

Researchers hope that by interacting with the toll-like receptor protein TLR-7 an experimental drug can help increase the immune system's ability to sense and attack HIV and HIV-infected cells.

Italian Study Explores Dual Drug Regimens as Maintenance Treatment Img

Italian Study Explores Dual Drug Regimens as Maintenance Treatment

Researchers found that around 90% of participants who were switched to a dual drug regimen maintained a suppressed viral load over the course of the study.

Combinations of Super Antibodies May Keep HIV at Bay Img

Combinations of Super Antibodies May Keep HIV at Bay

The results from this pilot study are exciting and raise many issues that need to be taken into account for future studies of broadly neutralizing antibodies.

Smartphone Intervention Found Helpful for Young Men Taking PrEP Img

Smartphone Intervention Found Helpful for Young Men Taking PrEP

U.S. researchers have developed PrEPmate, a text messaging service to increase PrEP adherence.